News

Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial led by UC San Francisco researchers has found. The approach can extend the time between debilitating drug

Johnny Holland has faced fierce foes for decades, first as a standout tackle in the National Football League, then as a beloved coach with the San Francisco 49ers. But when it comes to being poked by a nurse with a needle, the gridiron warrior shuts his eyes and scrunches his face. "No matter how

UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T cell therapy for multiple myeloma, the second most common malignancy among blood cancers. The

These cancer cells are on the march: They are migrating away from the human breast cancer tissue where they originated, in search of other tissues to invade. Cell biologist and engineer Matthew Kutys, PhD, and his team harness organoids – living tissues derived from patient tumors – to study how

The American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term beginning in June 2025. A long-time ASCO member and volunteer, Small will take office as president-elect immediately following the ASCO Annual Business Meeting in Chicago on

It is well known that tobacco smoke adversely affects the prognosis of adult cancers, including myeloid leukemia. But less is known about the effects in children. Now, researchers at UC San Francisco and UC Berkeley are investigating the impact of pre- and post-natal exposures to tobacco smoke on